九源基因(02566)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02566 九源基因

待上市 11-22 13:45:21

0.000

+0.000

--

最高0.000	最低0.000	成交量0.00
今开0.000	昨收0.000	日振幅0.00%
总市值0.00	流通市值0.00	总股本2.45亿
成交额0.00	换手率0.00%	流通股本1.09亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02566","market":"HK","secType":"STK","nameCN":"九源基因","latestPrice":0,"timestamp":1732254321598,"preClose":0,"halted":7,"volume":0,"delay":0,"floatShares":109096785,"shares":245398800,"eps":0,"marketStatus":"待上市","marketStatusCode":8,"change":0,"latestTime":"11-22 13:45:21","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732757400000},"ipoDetail":{"name":"九源基因","exchange":"SEHK","listingDate":"2024-11-28","sharesOutstanding":245398800,"sharesFloat":109096785,"offerAmount":45398800,"priceRange":"11.48  -  12.56","market":"HK","openProspectusDate":"2024-11-20","openProspectusUrl":"https://staticpdf.iqdii.com/stockdata/notice/02566/2024/2024112000020_c.pdf","purchaseBeginDate":"2024-11-20","purchaseEndDate":"2024-11-25","winningDate":"2024-11-27","currency":"HKD","minPurchaseQuantity":200,"peRate":22.47,"use":"1、约40.0%（或187.3百万港元）将分配至战略性重点治疗领域的选定在研产品的持续研发；\n2、约30.0%（或140.4百万港元）将用于现有及接近商业化产品的营销及商业化；\n3、约10.0%（或46.8百万港元）将用于寻求战略合作，以丰富在目标治疗领域的产品组合；\n4、约10.0%（或46.8百万港元）将用于制造系统，以建设新生产线，并升级及进一步自动化现有生产设施，从而为产品的潜在需求增长及新产品的推出做好准备；\n5、约10.0%（或46.8百万港元）将用于为营运资金及其他一般企业用途提供资金。","industryId":"204005","industryName":"医疗保健","business":"公司是一家总部设于浙江省的中国生物制药公司，拥有逾30年生物药品及医疗器械研发、生产及商业化经验。","subscribed":47.12,"marketCap":2817000000,"minimumCapital":2537.33,"overAllotment":true,"lotSize":200,"issueOpenRate":0.1,"subscribeGear":"200,400,600,800,1000,1200,1400,1600,1800,2000,3000,4000,5000,6000,7000,8000,9000,10000,20000,30000,40000,50000,60000,70000,80000,90000,100000,150000,200000,250000,300000,350000,400000,450000,500000,600000,700000,800000,900000,1000000,1500000,2000000,2270000"},"greyMarketDetail":{"greyDate":"2024-11-27","greyDateTimestamp":1732636800000,"greyOpeningTime":1732695300000,"greyClosingTime":1732703400000,"showGreyQuote":false,"openProspectusDate":"2024-11-20","listingDate":"2024-11-28"},"adr":0,"listingDate":1732723200000,"adjPreClose":0,"openAndCloseTimeList":[[1732239000000,1732248000000],[1732251600000,1732262400000]],"volumeRatio":0,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02566/wiki","defaultTab":"wiki","newsList":[{"id":"2484192917","title":"浙大网新：参股公司九源基因拟香港上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2484192917","media":"港股那点事","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484192917?lang=zh_cn&edition=full","pubTime":"2024-11-20 19:53","pubTimestamp":1732103580,"startTime":"0","endTime":"0","summary":"格隆汇11月20日｜浙大网新公告，参股公司九源基因拟在香港联交所主板上市，已于2024年11月20日披露招股章程。此次全球发售包括香港公开发售部分454万股H股和国际配售部分4085.88万股H股，发售价格区间为11.48-12.56港元。基石投资人认购总金额约3.5亿港元。九源基因专注于骨科、代谢性疾病、肿瘤学和血液学领域，骨修复材料“骨优导”在中国市场销售收入排名第一。浙大网新全资子公司网新创投持有九源基因上市前12.26%股份。九源基因预计2024年11月28日在香港联交所主板开始买卖。               \n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/bxjj/2024-11-20/doc-incwtmak2050905.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2024-11-20/doc-incwtmak2050905.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0122","BK0231","BK0114","BK0089","BK0030","02566","BK0018","BK0188","BK0142","BK0028","BK0154","600797","BK0038","BK0067"],"gpt_icon":0},{"id":"2484219475","title":"浙大网新(600797.SH)参股公司九源基因拟在香港联交所主板上市 公司当前持股12.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484219475","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484219475?lang=zh_cn&edition=full","pubTime":"2024-11-20 19:50","pubTimestamp":1732103434,"startTime":"0","endTime":"0","summary":"根据招股章程，九源基因于11月20日开始在香港公开发售，预计九源基因H股将于2024年11月28日开始在香港联交所主板买卖，股票代码2566。截至本公告披露日，公司全资子公司网新创投持有九源基因本次香港发行股份上市前12.26%的股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1213654.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0030","BK0067","BK0018","BK0038","BK0231","BK0089","02566","600797","BK0154","BK0188","BK0114","BK0142","BK0028","BK0122"],"gpt_icon":0},{"id":"2484199060","title":"新股孖展统计 | 11月20日","url":"https://stock-news.laohu8.com/highlight/detail?id=2484199060","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484199060?lang=zh_cn&edition=full","pubTime":"2024-11-20 19:22","pubTimestamp":1732101720,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，顺丰控股(06936)、九源基因(02566)正在招股中。截止11月20日，富途、辉立、耀才等券商合计为顺丰控股借出37.5014亿港元，超购逾5.3倍；合计为九源基因借出5.7904亿港元，超购逾9.3倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1213622.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0197","LU0405327494.USD","BK0028","02566","LU0405327148.USD","IE00B12V2V27.USD","BK0187","002352","IE00BYTNYN87.SGD","BK0196","06936","BK0232","IE00BYQNZ168.SGD"],"gpt_icon":0},{"id":"2484986411","title":"减肥药概念股！“九源基因”募5.46亿，首日认购已足额，基石超6成","url":"https://stock-news.laohu8.com/highlight/detail?id=2484986411","media":"活报告","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484986411?lang=zh_cn&edition=full","pubTime":"2024-11-20 18:13","pubTimestamp":1732097580,"startTime":"0","endTime":"0","summary":"来源：活报告九源基因招股日期为2024年11月20日至2024年11月25日，并预计于2024年11月28日在港交所挂牌上市。据捷利交易宝的新股孖展数据，截至11月20日港股收盘，九源基因的孖展总额约3.83亿港元，首日孖展认购已足额。认购资金方面，若不回拨，按发行中间价12.02港元计，全球发售的总募资额约为5.46亿港元，其中基石投资者约占3.50亿港元，其余国配约占1.41亿港元，公开发售约占5457万港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/cj/2024-11-20/doc-incwteuk5353588.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/cj/2024-11-20/doc-incwteuk5353588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02566"],"gpt_icon":0},{"id":"2484198619","title":"九源基因启动招股 百惠金控担任联席账簿管理人及联席牵头经办人","url":"https://stock-news.laohu8.com/highlight/detail?id=2484198619","media":"中宏网官微","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484198619?lang=zh_cn&edition=full","pubTime":"2024-11-20 17:08","pubTimestamp":1732093680,"startTime":"0","endTime":"0","summary":"杭州九源基因工程股份有限公司，于2024年11月20日至11月25日期间招股，百惠金控团队担任联席账簿管理人及联席牵头经办人。　　作为本次IPO项目的联席账簿管理人及联席牵头经办人，百惠金控团队积极利用自身资源，全面展示九源基因的企业优势和市场潜力，助力其在中国香港上市，进一步提升企业价值和竞争力。百惠金控看好九源基因将将以此次上市为契机，推动公司的研发结果及发展，从而在全球生物医药市场中占据更有利的竞争地位。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-11-20/doc-incwteuk5345462.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-11-20/doc-incwteuk5345462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02566"],"gpt_icon":0},{"id":"2485475029","title":"九源基因上半年利润超1亿元，“减肥神药”即将港股上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2485475029","media":"美港探案","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485475029?lang=zh_cn&edition=full","pubTime":"2024-11-20 14:40","pubTimestamp":1732084800,"startTime":"0","endTime":"0","summary":"九源基因上半年利润超1亿元，“减肥神药”即将港股上市本文为美港探案原创作者：舟木编辑：探长X继今年1月和7月港交所两次递表后，手握一款司美格鲁肽生物类似药的九源基因正式通过港交所上市聆讯。不过，九源基因也表示，在港交所上市后，公司或将不再拥有上市规则所界定的任何控股股东，而华东医药及中美华东仍将为公司的单一最大股东集团。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzIzNDE1NDIyMg==&mid=2653418145&idx=1&sn=24648acd14221a183fa74c4960efc646&chksm=f329e320c45e6a36f86489c5f068665c311f04ca3bb16f29f024b8c1614b2934f617a49459b5#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["02566","YANG","HSCEI","HSTECH"],"gpt_icon":1},{"id":"2484554161","title":"九源基因招股，引入复星、阿里健康、健友股份、九州通等7名基石投资者，11月28日香港上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2484554161","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484554161?lang=zh_cn&edition=full","pubTime":"2024-11-20 13:22","pubTimestamp":1732080120,"startTime":"0","endTime":"0","summary":"　　来自浙江杭州的生物制药公司九源基因，于今日起至下周一招股，预计2024年11月28日在港交所挂牌上市，华泰国际独家保荐。　　九源基因，计划全球发售4539.88万股H股，其中90%为国际发售、10%为公开发售，另有15%超额配股权，每股发售价介乎11.48港元至12.56港元，每手200股，最多募资约5.70亿港元。8款已上市产品包括骨科、肿瘤、血液领域的1款创新药械组合，2款生物制品、5款化学药品。九源基因已建立覆盖全国的销售及分销网络。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/2024-11-20/doc-incwsueq5437050.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/2024-11-20/doc-incwsueq5437050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0012","BK0188","BK1247","BK1610","BK1571","BK1515","BK0077","BK0187","BK0183","BK1501","BK1589","BK0046","BK0196","BK1584","BK0039","02566","603707","BK0097","BK0146","BK1591","BK0250","00241","BK1189","BK0239","BK1502","600998","BK0028","BK1142","BK0201","BK0186"],"gpt_icon":0},{"id":"2484107189","title":"新股招股 | 九源基因今起招股，一手入场费2537.33港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484107189","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484107189?lang=zh_cn&edition=full","pubTime":"2024-11-20 08:20","pubTimestamp":1732062000,"startTime":"0","endTime":"0","summary":"复星医药、阿里健康等为基石投资者。","market":"hk","thumbnail":"https://static.tigerbbs.com/bb6231753b131648612d414a9feed43f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/bb6231753b131648612d414a9feed43f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkzmt/2024-11-20/doc-incwsiqw2292973.shtml","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"新股招股 | 九源基因11月20日起招股，一手入场费2537.33港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02566"],"gpt_icon":0},{"id":"2484427900","title":"九源基因11月20日-11月25日招股，拟全球发售4539.88万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2484427900","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484427900?lang=zh_cn&edition=full","pubTime":"2024-11-20 07:20","pubTimestamp":1732058456,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九源基因(02566)于2024年11月20日至2024年11月25日招股，公司拟全球发售4539.88万股H股，其中，香港公开发售占约10%;国际发售占约90%。发售价将为每股发售股份11.48-12.56港元。预期H股将于2024年11月28日(星期四)上午9时正在联交所开始买卖。H股将以每手200股H股进行买卖。","market":"us","thumbnail":"https://static.tigerbbs.com/0bc9411b92daca5fa6f9496d92394df3","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/0bc9411b92daca5fa6f9496d92394df3"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1213184.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02566"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0085},{"period":"1month","weight":-0.0438},{"period":"3month","weight":0.1129},{"period":"6month","weight":0.0533},{"period":"1year","weight":0.1052},{"period":"ytd","weight":0.1498}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"exchange":"SEHK","name":"九源基因","nameEN":"JIUYUAN GENE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"九源基因(02566)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供九源基因(02566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"九源基因,02566,九源基因股票,九源基因股票老虎,九源基因股票老虎国际,九源基因行情,九源基因股票行情,九源基因股价,九源基因股市,九源基因股票价格,九源基因股票交易,九源基因股票购买,九源基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"九源基因(02566)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供九源基因(02566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}